HPV vaccine ‘substantially’ reduces cervical cancer risk: study

Human papillomavirus (HPV) vaccination substantially lowered the risk of cervical cancer, especially when administered early, according to a new study.

Researchers in Sweden published their findings on Thursday in the New England Journal of Medicine, and said evidence was otherwise lacking on the issue.

The study found that those vaccinated before age 17 had an 88% lower risk of cervical cancer than those never vaccinated.

Human papillomavirus (HPV) vaccination substantially lowered the risk of <a data-cke-saved-href="https://www.foxnews.com/category/health/cancer/cervical-cancer" href="https://www.foxnews.com/category/health/cancer/cervical-cancer" target="_blank">cervical cancer</a>, especially when administered early, per a new study.<br data-cke-eol="1">
(iStock)

Human papillomavirus (HPV) vaccination substantially lowered the risk of <a data-cke-saved-href=”https://www.foxnews.com/category/health/cancer/cervical-cancer” href=”https://www.foxnews.com/category/health/cancer/cervical-cancer” target=”_blank”>cervical cancer</a>, especially when administered early, per a new study.<br data-cke-eol=”1″>
(iStock)

CORONAVIRUS CAUSED SPIKE IN GOOGLE SEARCH FOR THIS SYMPTOM

“HPV is the most common sexually transmitted infection,” according to the Centers for Disease Control and Prevention (CDC). Those with weakened immune systems may have more difficulty fighting the virus, which can lead to health issues like genital warts and cancers. The CDC recommends two doses of the HPV vaccine for boys

Read More

HPV Vaccination and Substantial Reduction in Cervical Cancer

Quadrivalent human papillomavirus (HPV) vaccination was associated with a substantial reduction in the incidence of cervical cancer in a Swedish review of more than 1 million girls and women vaccinated from 2006–2017.

It’s been shown that the vaccine (Gardasil) helps prevent genital warts and high-grade cervical lesions, but until now, data on the ability of the vaccine to prevent cervical cancer, although widely assumed, had been lacking.

“Our results extend [the] knowledge base by showing that quadrivalent HPV vaccination is also associated with a substantially reduced risk of invasive cervical cancer, which is the ultimate intent of HPV vaccination program,” said investigators led by Jiayao Lei, PhD, a researcher in the Department of Medical Epidemiology and Biostatistics at the Karolinska Institute, Stockholm, Sweden.

The study was published online October 1 in The New England Journal of Medicine.

“This work provides evidence of actual cancer prevention,” commented Diane Harper, MD,

Read More

HPV vaccine ‘may significantly’ lower cervical cancer risk, study finds

Sept. 30 (UPI) — Women vaccinated against HPV may be at significantly lower risk for developing cervical cancer, according to a study published Wednesday by the New England Journal of Medicine.

Girls who received the shot before turning 17 reduced their risk of cervical cancer by 88% compared to unvaccinated women, while women inoculated against the virus between ages 17 and 30 cut their risk in half, the data showed.

“HPV vaccination is protective not only against cellular changes that can be precursors to cervical cancer, but also against actual invasive cervical cancer,” study co-author Jiayao Lei said in a statement.

“[This] is something we have long suspected,” said Lei, a researcher at the Department of Medical Epidemiology and Biostatistics at Karolinska Institute in Sweden.

The most common sexually transmitted infection in the United States, HPV, or human papillomavirus, is a group of viruses that can cause genital warts and

Read More

Authors Retract Paper on HPV Vaccine and Preterm Birth

The authors of a 2018 paper purporting to find that the HPV vaccine guards against preterm birth have retracted the article after discovering they made a statistical error which could have masked the opposite effect.

The researchers, from New Zealand, also failed to appropriately disclose their financial ties to a company, CSL Limited, which owns the rights to the HPV vaccine in Australia and New Zealand.

The paper, “Association of prior HPV vaccination with reduced preterm birth: A population based study,” was published in Vaccine, an Elsevier journal. According to the abstract:

Emerging evidence suggests that HPV infection is associated with negative pregnancy outcomes such as preterm birth (PTB), and pre-eclampsia. We aimed to determine if prior HPV vaccination reduced adverse pregnancy outcomes. … PTB (OR: 0.87; CI 0.78, 0.96)) was significantly lower for women who previously received the HPV vaccine. A dose response effect was found with each

Read More